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Cells in a Model of Early Type II Diabetes
Bo Wang, Runxia Tian, Zhao-Jun Liu, Alan Livingstone,
Omaida C. Velazquez. Surgery, University of Miami,
Miami, Fla
Objectives: Repeated, lowdose injections of Streptozo-
tocin (STZ) create amodel of Type II DiabetesMellitus. We
utilize thismodel to investigate the potential pro-repair effect
of syngeneic (equivalent to autologous) bone marrow-
derived mesenchymal stem cells (BMD-MSC) in Diabetes.
Methods: STZ (40 mg/Kg) was administered, daily,
for ﬁve days, i.p., in C57BL6 mice (N ¼ 12). Weekly blood
glucose levels (BG) were monitored by 2-hour Glucose
Tolerance Test (GTT) for ﬁve weeks after. Glucose intoler-
ance (150 < BG < 200 mg/dL) was used as the trigger for
treatment. The mice were then divided in two groups (N ¼
6/group). Control group received PBS and treatment
group received MSC (1x10
ˇ
6), by tail vein infusion. MSC
were obtained by culturing BMD cells from donor mice
(N ¼ 3) in MesenCult medium. b-cell activity was
measured by immunohistochemistry, and serum level of
insulin was assessed by C-peptide test.
Results: At baseline and post-STZ-induction, GTT
between control and treatment group did not differ
signiﬁcantly. However, at week 3 the MSC treatment
group’s GTT normalized and the effect is sustained by
week 5 (Fig). Control group continues to have signiﬁcant
glucose intolerance. Longer follow up is ongoing.
Conclusions: Systemic injection of a single MSC
treatment improves the Glucose Tolerance in a murine
model of Type II Diabetes. The ﬁndings will require
conﬁrmation in genetic murine models, yet depict a highly
promising novel concept for the treatment of Diabetes.
Author Disclosures: Z. Liu: Nothing to disclose; A. Liv-
ingstone: Nothing to disclose; R. Tian: Nothing to
disclose; O. C. Velazquez: Nothing to disclose; B.
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Supplemental Oxygen Reverses Hypoxia Induced
Smooth Muscle Cell Proliferation by Modulating
HIF-alpha and VEGF Levels in a Rabbit
Arteriovenous Fistula ModelGreen1, Sabita Roy1, Steven Santilli1. 1Department of
Surgery, Univ. of Minnesota, Minneapolis, Minn;
2Zhongnan Hospital Wuhan University, Wuhan, China
Objectives: Numerous mechanisms for the formation
of intimal hyperplasia have been proposed but none have
been proven or accepted. Our research focuses on the
potential role of Hypoxia Inducible Factors (HIFs),
VEGF, and PDGF as well as the ERK, PI3-K/AKT
pathway in hypoxia mediated intimal hyperplasia processes.
Methods: Rabbits were randomized into different
experimental groups with varying oxygen exposure and
receipt of surgery. Plasma samples were collected at desig-
nated intervals in which cytokines and smooth muscle cell
proliferation were measured. In addition, cell specimens
were exposed to hyperoxic, normoxic, and hypoxic envi-
ronments with cytokines measured at various time points.
Results: Placement of an arteriovenous ﬁstula resulted
in hypoxia induced HIF stabilization with a concurrent
increase in VEGF. Activation of VEGF receptors on smooth
muscle cells through ERK1 and AKT pathways resulted in
signiﬁcant smooth muscle cell proliferation and migration.
These effects are dramatically reduced in animals that are
exposed to a hyperoxic environment of 30% oxygen.
Conclusions: Our results suggest that short-term
administration of supplemental oxygen inhibits HIFs and
VEGF signaling to reduce smooth muscle proliferation in
the local blood vessel. These results provide strong support
for the therapeutic use of supplemental oxygen following
arterial surgery to reduce intimal hyperplasia. These ﬁnd-
ings also provide a nidus for future studies into the mech-
anisms of hypoxia induced intimal hyperplasia.
Author Disclosures: D. L. Green: Nothing to disclose; C.
Lata: Nothing to disclose; S. Roy: Nothing to disclose; A.
Santilli: Nothing to disclose; S. Santilli: Nothing to
disclose; J. Wan: Nothing to disclose.PS180.
The Gene Expression of Adenosine Receptors in the
Processes of Contrast Induced Nephropathy in
Mouse Kidney
Luyu Yao1, Gopi K. Kolluru2, Kevil G. Christopher2,
Wayne W. Zhang1. 1Louisiana State University Health
Sciences Center, Surgery Department, Shreveport, LA;
2Louisiana State University Health Sciences Center,
Pathology Department, Shreveport, La
Objectives: Contrast Induced Nephropathy (CIN) is
the third leading cause of hospital acquired renal failure,
which is a common complication following endovascular
surgery procedures. The mechanism of CIN is not fully
understood. Adenosine receptors (AR) regulate various
physiological activities in kidney. We hypothesized that
adenosine and its receptors may play a role in development
of CIN. The objectives of this study were to investigate the
expression changes of the four subtypes of adenosine recep-
tors (A1AR, A2AAR, A2BAR, and A3AR) following
administration of contrast agent in mice.
Methods: C57B1/6J mice were randomized to treat-
ment and control groups. Iodixanol, a commonly used
contrast agent, was administered to treatment groups
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0.75gI/kg and 2.75gI/kg. PBS was given to the mice in
control group. Mice kidneys were harvested at day 3 and
day 7 following Iodixanol administration. RNA and
protein were then extracted. qRT -PCR and Western
blot were used to quantify A1AR, A2AAR, A2BAR, and
A3AR RNA and protein expression respectively, with
GAPDH as endogenous control.
Results: qRT-PCR showed that Iodixanol induced
AR transcription, speciﬁcally in the group treated with
2.75gI/kg at day 3 after injection. The RNA levels in all
the four subtypes of ARs were increased 2-3 folds at day
3, but returned to normal at day 7 in Iodixanol groups
compared to PBS controls. The Western blot results
showed that A1AR, A2AAR, A3AR expressions were
increased 1.5-2 folds in Iodixanol group at day 3 compare
to PBS control. A2BAR expression was very low in normal
physiological condition and no signiﬁcant changes were
detected by western blot.
Conclusions: Our results indicate that Iodixanol
induces adenosine receptor gene expression in mice. Aden-
osine receptors may play a role in the development of CIN.
Further investigation on the correlation between adenosine
receptor gene expression and severity of CIN will be
preformed.
Author Disclosures: K. G. Christopher: Nothing to
disclose; G. K. Kolluru: Nothing to disclose; L. Yao:
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Inhibition of Angiogenesis and Endothelial Cell
Function by WISP-1/CCN4
Zhao-Jun Liu, Yurong Tan, Hongwei Shao, Yan Li,
Omaida C. Velazquez. Surgery, Univ Miami, Miami, Fla
Objectives: Wnt-induced secreted protein-1 (WISP-
1/CCN4) is involved in regulating cell proliferation,
survival/apoptosis, migration and tumor growth. We
previously observed that tumor stroma-produced WISP-
1/CCN4 plays a critical role in melanoma growth and
tumor angiogenesis. We sought to determine the biologic
effect of WISP-1/CCN4 on endothelial cell biology and
angiogenesis.
Methods: The effects of WISP-1/CCN4 on cell
growth and migration of human endothelial cells (EC)
were examined by MTT and transwell-migration assay.
Two- and three-dimensional (2D and 3D) angiogenesis
models were used to study the role of WISP-1/CCN4 in
vascular network formation of EC. Melanoma xenograft
murine model was employed to examine the biological
effect of WISP-1/CCN4 on tumor angiogenesis and
growth. Human melanoma cells transduced with WISP-
1/lentivirus or GFP/lentivirus were xenografted on skin
of SCID mice (n ¼ 6/group). Expression of exogenous
WISP-1/CCN4 in transduced melanoma cells was vali-
dated by Western blot. Tumor angiogenesis was assessed
by mouse whole-body Dil-perfusion and tumor tissue
confocal microscopy. Tumor size was measured to deter-
mine tumor growth.Results: WISP-1/CCN4 inhibited cell growth and
migration of EC in vitro. Vascular network formation of
EC in 2D- and 3D angiogenesis models was suppressed
considerably (P < .01) by supplementation of ghWISP-1
(100 ng/mL) in both Matrigel (2D) and type I collagen
gel (3D). Elevated expression of WISP-1 in tumor tissue
signiﬁcantly antagonized tumor angiogenesis and retarded
tumor growth in vivo.
Conclusions: Our results revealed a novel role of
WISP-1/CCN4 in negatively regulating endothelial cell
biology and angiogenesis, implicating that WISP-1/
CCN4 may serve as a novel target for cancer therapeutic
intervention.
Author Disclosures: Y. Li: Nothing to disclose; Z. Liu:
Nothing to disclose; H. Shao: Nothing to disclose; Y.
Tan: Nothing to disclose; O. C. Velazquez: Nothing to
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Differential Proliferative and Migratory Activity of
Human Myoblasts Isolated from CLI and Control
Patients
Rebekah Yu, Shyam Kolvekar, Daryll Baker, George
Hamilton, David Abraham, Janice Tsui. Division of
Surgery and Interventional Science, Universtiy College
London, London, United Kingdom
Objectives: Patients with critical limb ischemia (CLI)
have attributable myopathy that impairs their functional
ability as well as dampening the positive effect of successful
revascularization outcomes. Adult skeletal muscle retains
the potential to repair following different injury patterns.
We aim to investigate the potential differences in prolifera-
tion and migration capability of human myoblasts with CLI
and asymptomatic control patients.
Methods: Gastrocnemius muscle biopsies were ob-
tained from patients with critical limb ischemia and control
samples were obtained from non-ischemic patients.
Human myoblasts were isolated and cultured from each
sample and stained with the myoblast marker desmin.
Conﬁrmed myoblast cultures (<5% alternative cell type
contamination) were then used to investigate the prolifera-
tive capability (MTT assay) as well as migratory potential
(scratch-wound assay) under both ischemic and normoxic
conditions of each group.
Results: Myoblasts isolated from CLI patients
demonstrated greater proliferative ability in comparison
to control samples. However, control samples revealed
greater capacity to heal scratch wounds made in a mono-
layer of myoblasts in both normoxia and hypoxic
conditions.
Conclusions: Isolation of human myoblasts, especially
from disease groups provides a useful platform to perform
in vitro analysis to better understand and characterise
pathology. CLI myoblasts exhibited enhanced proliferative
but diminished migratory potential in comparison to
control myoblasts.
Author Disclosures: D. Abraham: Nothing to disclose;
D. Baker: Nothing to disclose; G. Hamilton: Nothing
